These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma. Lian F; Cui Y; Zhou C; Gao K; Wu L PLoS One; 2015; 10(3):e0121499. PubMed ID: 25775010 [TBL] [Abstract][Full Text] [Related]
4. Differential microRNA expression in childhood B-cell precursor acute lymphoblastic leukemia. Ju X; Li D; Shi Q; Hou H; Sun N; Shen B Pediatr Hematol Oncol; 2009 Jan; 26(1):1-10. PubMed ID: 19206004 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma. Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475 [TBL] [Abstract][Full Text] [Related]
6. miRNA-199a-3p in plasma as a potential diagnostic biomarker for gastric cancer. Li C; Li JF; Cai Q; Qiu QQ; Yan M; Liu BY; Zhu ZG Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S397-405. PubMed ID: 22956063 [TBL] [Abstract][Full Text] [Related]
7. Circulating MicroRNA-26a in Plasma and Its Potential Diagnostic Value in Gastric Cancer. Qiu X; Zhang J; Shi W; Liu S; Kang M; Chu H; Wu D; Tong N; Gong W; Tao G; Zhao Q; Qiang F; Zhu H; Wu Q; Wang M; Zhang Z PLoS One; 2016; 11(3):e0151345. PubMed ID: 27010210 [TBL] [Abstract][Full Text] [Related]
8. Differential expression of specific microRNA and their targets in acute myeloid leukemia. Cammarata G; Augugliaro L; Salemi D; Agueli C; La Rosa M; Dagnino L; Civiletto G; Messana F; Marfia A; Bica MG; Cascio L; Floridia PM; Mineo AM; Russo M; Fabbiano F; Santoro A Am J Hematol; 2010 May; 85(5):331-9. PubMed ID: 20425795 [TBL] [Abstract][Full Text] [Related]
9. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles. Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605 [TBL] [Abstract][Full Text] [Related]
10. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi. Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773 [TBL] [Abstract][Full Text] [Related]
11. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer. Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263 [TBL] [Abstract][Full Text] [Related]
12. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study. Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272 [TBL] [Abstract][Full Text] [Related]
13. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252 [TBL] [Abstract][Full Text] [Related]
14. MiRNA-199a-3p: A potential circulating diagnostic biomarker for early gastric cancer. Li C; Li JF; Cai Q; Qiu QQ; Yan M; Liu BY; Zhu ZG J Surg Oncol; 2013 Aug; 108(2):89-92. PubMed ID: 23733518 [TBL] [Abstract][Full Text] [Related]
15. Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05). Joerger M; Baty F; Früh M; Droege C; Stahel RA; Betticher DC; von Moos R; Ochsenbein A; Pless M; Gautschi O; Rothschild S; Brauchli P; Klingbiel D; Zappa F; Brutsche M Lung Cancer; 2014 Aug; 85(2):306-13. PubMed ID: 24928469 [TBL] [Abstract][Full Text] [Related]
16. Human miR-1228 as a stable endogenous control for the quantification of circulating microRNAs in cancer patients. Hu J; Wang Z; Liao BY; Yu L; Gao X; Lu S; Wang S; Dai Z; Zhang X; Chen Q; Qiu SJ; Wu Y; Zhu H; Fan J; Zhou J; Wang J Int J Cancer; 2014 Sep; 135(5):1187-94. PubMed ID: 24488924 [TBL] [Abstract][Full Text] [Related]
17. Circulating microRNAs identified in a genome-wide serum microRNA expression analysis as noninvasive biomarkers for endometriosis. Wang WT; Zhao YN; Han BW; Hong SJ; Chen YQ J Clin Endocrinol Metab; 2013 Jan; 98(1):281-9. PubMed ID: 23118427 [TBL] [Abstract][Full Text] [Related]
18. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer. Jiang X; Du L; Wang L; Li J; Liu Y; Zheng G; Qu A; Zhang X; Pan H; Yang Y; Wang C Int J Cancer; 2015 Feb; 136(4):854-62. PubMed ID: 24961907 [TBL] [Abstract][Full Text] [Related]
19. [Association between expression of plasma miRNA and the risk of childhood acute lymphocytic leukemia]. Yuan DM; Wu SY; Huang SL; Jiang WC; Ke YB Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Sep; 38(9):1252-1258. PubMed ID: 28910942 [No Abstract] [Full Text] [Related]
20. MicroRNA profiling reveals aberrant microRNA expression in adult ETP-ALL and functional studies implicate a role for miR-222 in acute leukemia. Coskun E; Neumann M; Schlee C; Liebertz F; Heesch S; Goekbuget N; Hoelzer D; Baldus CD Leuk Res; 2013 Jun; 37(6):647-56. PubMed ID: 23522449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]